The following is the trial balance for Supreme Limited as at 31 December 2019. Supreme Limited Trial Balance as at 31 December 2019 Cr $ Dr $ 130,000 142,000 480,000 Accounts receivable Cash Equipment Accumulated depreciation - equipment 6% note payable Ordinary shares, 500,000 shares authorized, 100,000 shares issued Retained earnings Cash dividends Service revenue Salary expense Rent expense Depreciation expense - equipment 90,000 120,000 310,000 231,000 40,000 323,000 112,000 160,000 10,000 1,074,000 1,074,000 Additional information: (i) On 28 December 2019, the company declared final cash dividends of $60,000. The final cash dividends would be paid on 28 January 2020. No entry had been made for this transaction when preparing the above trial balance. (ii) The 6% note payable shown in the trail balance was a one-year note signed on 1 April 2019. The note requires payment of principal and interest at maturity. No entry had been made for the accrual of interest at the year end. (iii) The ordinary shares issued by Supreme Limited have no par value. Required: For Supreme Limited, (a) prepare the income statement for the year ended 31 December 2019. (5 marks) (b) prepare the statement of changes in equity for the year ended 31 December 2019. (4 marks) (c) prepare the classified statement of financial position as at 31 December 2019. (15 marks)